From genome-wide arrays to tailor-made biomarker readout - Progress towards routine analysis of skin sensitizing chemicals with GARD.

Allergic contact dermatitis (ACD) initiated by chemical sensitizers is an important public health concern. To prevent ACD, it is important to identify chemical allergens to limit the use of such compounds in various products. EU legislations, as well as increased mechanistic knowledge of skin sensitization have promoted development of non-animal based approaches for hazard classification of chemicals. GARD is an in vitro testing strategy based on measurements of a genomic biomarker signature. However, current GARD protocols are optimized for identification of predictive biomarker signatures, and not suitable for standardized screening. This study describes improvements to GARD to progress from biomarker discovery into a reliable and cost-effective assay for routine testing. Gene expression measurements were transferred to NanoString nCounter platform, normalization strategy was adjusted to fit serial arrival of testing substances, and a novel strategy to correct batch variations was presented. When challenging GARD with 29 compounds, sensitivity, specificity and accuracy could be estimated to 94%, 83% and 90%, respectively. In conclusion, we present a GARD workflow with improved sample capacity, retained predictive performance, and in a format adapted to standardized screening. We propose that GARD is ready to be considered as part of an integrated testing strategy for skin sensitization.

[1]  M. Lindstedt,et al.  Evaluation of high throughput gene expression platforms using a genomic biomarker signature for prediction of skin sensitization , 2014, BMC Genomics.

[2]  R. Saracci,et al.  Describing the validity of carcinogen screening tests. , 1979, British Journal of Cancer.

[3]  Coralie Dumont,et al.  Analysis of the Local Lymph Node Assay (LLNA) variability for assessing the prediction of skin sensitisation potential and potency of chemicals with non-animal approaches. , 2016, Toxicology in vitro : an international journal published in association with BIBRA.

[4]  Robert Landsiedel,et al.  Putting the parts together: combining in vitro methods to test for skin sensitizing potentials. , 2012, Regulatory toxicology and pharmacology : RTP.

[5]  C. Borrebaeck,et al.  Prediction of Chemical Respiratory Sensitizers Using GARD, a Novel In Vitro Assay Based on a Genomic Biomarker Signature , 2015, PloS one.

[6]  Jennifer L. Osborn,et al.  Direct multiplexed measurement of gene expression with color-coded probe pairs , 2008, Nature Biotechnology.

[7]  H. Maibach,et al.  Prevalence of patch test results from 1970 to 2002 in a multi‐centre population in North America (NACDG) , 2007, Contact dermatitis.

[8]  Malin Lindstedt,et al.  The GARD assay for assessment of chemical skin sensitizers. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  R J Fielder,et al.  Local lymph node assay - validation, conduct and use in practice. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[10]  Ian Kimber,et al.  Compilation of Historical Local Lymph Node Data for Evaluation of Skin Sensitization Alternative Methods , 2005, Dermatitis : contact, atopic, occupational, drug.

[11]  Takao Ashikaga,et al.  In silico risk assessment for skin sensitization using artificial neural network analysis. , 2015, The Journal of toxicological sciences.

[12]  C. Hansson,et al.  Chemical changes in rubber allergens during vulcanization , 2007, Contact dermatitis.

[13]  Z. Szallasi,et al.  Reliability and reproducibility issues in DNA microarray measurements. , 2006, Trends in genetics : TIG.

[14]  Takao Ashikaga,et al.  Predictive performance for human skin sensitizing potential of the human cell line activation test (h‐CLAT) , 2011, Contact dermatitis.

[15]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[16]  J. Geier,et al.  Occupational rubber glove allergy: results of the Information Network of Departments of Dermatology (IVDK), 1995–2001 , 2003, Contact dermatitis.

[17]  Corinna Cortes,et al.  Support-Vector Networks , 1995, Machine Learning.

[18]  A. M. Api,et al.  Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects , 2011, Cellular and Molecular Life Sciences.

[19]  Allan Linneberg,et al.  The epidemiology of contact allergy in the general population – prevalence and main findings , 2007, Contact dermatitis.

[20]  Xiaoqian Jiang,et al.  Doubly Optimized Calibrated Support Vector Machine (DOC-SVM): An Algorithm for Joint Optimization of Discrimination and Calibration , 2012, PloS one.

[21]  D. Murphy.  Gene expression studies using microarrays: principles, problems, and prospects. , 2002, Advances in physiology education.

[22]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[23]  Thomas Lengauer,et al.  ROCR: visualizing classifier performance in R , 2005, Bioinform..

[24]  Andreas Schepky,et al.  Genomic allergen rapid detection in-house validation--a proof of concept. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[25]  C. Svedman,et al.  Reaction profile in patch testing with allergens formed during vulcanization of rubber , 2014, Contact dermatitis.

[26]  Cedric E. Ginestet.  ggplot2: Elegant Graphics for Data Analysis , 2011 .

[27]  G Frank Gerberick,et al.  Allergic Contact Dermatitis , 1998, Springer Berlin Heidelberg.

[28]  Nicolas Servant,et al.  A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis , 2013, Briefings Bioinform..

[29]  Martina Klaric,et al.  Systematic evaluation of non-animal test methods for skin sensitisation safety assessment. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[30]  Takao Ashikaga,et al.  Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals , 2015, Journal of applied toxicology : JAT.

[31]  A. Kansky,et al.  Increase in contact allergy to fragrances: patch‐test results 1989–1998 , 2000, Contact dermatitis.

[32]  B H Margolin,et al.  ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods. , 2001, Regulatory toxicology and pharmacology : RTP.

[33]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[34]  Andreas Natsch,et al.  The Nrf2-Keap1-ARE toxicity pathway as a cellular sensor for skin sensitizers--functional relevance and a hypothesis on innate reactions to skin sensitizers. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  Nathalie Alépée,et al.  The Myeloid U937 Skin Sensitization Test (U-SENS) addresses the activation of dendritic cell event in the adverse outcome pathway for skin sensitization. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[36]  Lucila Ohno-Machado,et al.  The use of receiver operating characteristic curves in biomedical informatics , 2005, J. Biomed. Informatics.

[37]  H. Dickel,et al.  Occupational skin diseases in Northern Bavaria between 1990 and 1999: a population‐based study , 2001, The British journal of dermatology.

[38]  Petra Kern,et al.  A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation , 2013, Journal of applied toxicology : JAT.

[39]  Malin Lindstedt,et al.  A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests , 2011, BMC Genomics.

[40]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[41]  H. Sakaguchi,et al.  Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[42]  Max Kuhn,et al.  caret: Classification and Regression Training , 2015 .

[43]  Setsuya Aiba,et al.  Skin sensitization risk assessment model using artificial neural network analysis of data from multiple in vitro assays. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.

[44]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[45]  G Frank Gerberick,et al.  Development of a peptide reactivity assay for screening contact allergens. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[46]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[47]  Judy Strickland,et al.  Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative weight of evidence and adaptive testing strategy , 2015, Archives of Toxicology.

[48]  L. Parish.  Test concentrations and vehicles for 4350 chemicals, 3rd ed., DeGroot AC. Acdegroot publishing, Wapserveen, The Netherlands (2008), 455 pp; List price: €129.95 , 2010 .

[49]  Claus Lindbjerg Andersen,et al.  Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets , 2004, Cancer Research.

[50]  Steven R. Cohen,et al.  The relationship between atopic dermatitis and contact dermatitis. , 2003, Clinics in dermatology.

[51]  Malin Lindstedt,et al.  Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency , 2014, BMC Pharmacology and Toxicology.

[52]  Donald Y M Leung,et al.  Allergic skin diseases. , 2010, The Journal of allergy and clinical immunology.

[53]  Peng Liang.  MAQC papers over the cracks , 2007, Nature Biotechnology.